// App-Quantinova.ai

: Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension - results from a large European multicentre randomised controlled trial

Researchers

Presenter

  • Ekkehard Grünig

Principal Investigators

  • Andrew J. Peackock

  • Christina Eichstaedt

  • Nicola Benjamin

  • Robert Nechwatal

  • Silvia Ulrich

  • Stéphanie Saxer

  • Maurizio Bussotti

  • Marinella Sommaruga

  • Stefano Ghio

  • Lina Gumbiene

  • Egle Palevičiūtė

  • Elena Jurevičienė

  • Antonio Cittadini

  • Anna A. Stanziola

  • Alberto M. Marra

  • Gabor Kovacs

  • Horst Olschewski

  • Joan-Albert Barberà

  • Isabel Blanco

  • Martijn A. Spruit

  • Frits M.E. Franssen

  • Anton Vonk Noordegraaf

  • Abílio Reis

  • Mário Santos

  • Sofia Goncalves Viamonte

  • Heleen Demeyer

  • Marion Delcroix

  • Eduardo Bossone

  • Martin Johnson

Medical Centers

  • Centre for Pulmonary Hypertension, Thoraxclinic at the University Hospital Heidelberg and Translational Lung Research Centre Heidelberg (TLRC), German Centre for Lung Research (DZL), Heidelberg, Germany

  • Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, United Kingdom

  • Rehabilitation Center Koenigstuhl, Heidelberg, Germany

  • Pulmonology UniversityHospital Zurich, Zurich, Switzerland

  • Cardiac Rehabilitation Department, IRCCS Maugeri Clinical Scientific Institutes, Milan, Italy

  • Dept. of Cardiology Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Competence Centre of Pulmonary Hypertension and Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania

  • Department of Cardiac Surgery, University Hospital Salerno, Salerno, Italy,

  • Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy

  • Department of Cardiovascular Imaging, IRCCS S.D.N, Naples, Italy

  • Department Internal Medicine, Medical University of Graz, Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria,

  • 1. Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain. 2. Biomedical Research Networking Center on Respiratory Diseases (CIBERES, Madrid, Spain., Barcelona, Spain

  • Department of Research and Education, CIROh and Devlopment, Ciro, Horn, Netherlands; Department of Respiratory Medicine, Maastricht University Medical Centre (MUMC+, Maastricht, The Netherlands; NUTRIM School of Nutrition and Translational Research in Metabolism, Horn, Netherlands

  • Department of Research and Education, CIROh and Devlopment, Ciro, Horn, Netherlands; Department of Respiratory Medicine, Maastricht University Medical Centre (MUMC+, Maastricht, The Netherlands; NUTRIM School of Nutrition and Translational Research in Metabolism, Horn, Netherlands

  • Amsterdam UMC, VU University Medical Center, Department of Pulmonology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands

  • Department of Internal Medicine, Hospital Geral de Santo António, Porto, Portugal,

  • Centro de Reabilitação do Norte, Porto, Portugal

  • Department of Hematology, University Hospital Leuven, Leuven, Belgium

  • Department of Cardiology, Antonio Carderelli Hospital, Naples, Italy

Locations

  • Germany

  • United Kingdom

  • Switzerland

  • Italy

  • Lithuania

  • Austria

  • Spain

  • Netherlands

  • Portugal

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Cardiovascular (CVS)

Disease

  • Chronic thromboembolic pulmonary hypertension

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved